MCM
MRNA icon

MAI Capital Management’s Moderna MRNA Stock Holding History

MAI Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$304K Buy
4,345
+2,200
+103% +$114K ﹤0.01% 1578
2026
Q1 		$109K Sell
2,145
-685
-24% -$32K ﹤0.01% 1782
2025
Q4 		$83.5K Buy
2,830
+200
+8% +$5.43K ﹤0.01% 1738
2025
Q3 		$67.9K Sell
2,630
-163
-6% -$4.55K ﹤0.01% 1766
2025
Q2 		$77.1K Sell
2,793
-146
-5% -$3.85K ﹤0.01% 1624
2025
Q1 		$83.3K Sell
2,939
-8
-0.3% -$284 ﹤0.01% 1486
2024
Q4 		$123K Buy
+2,947
New +$141K ﹤0.01% 1344
2024
Q3 		– Sell
-4,622
Closed -$549K – 1193
2024
Q2 		$549K Buy
4,622
+380
+9% +$48.1K 0.01% 777
2024
Q1 		$452K Sell
4,242
-513
-11% -$51.7K ﹤0.01% 840
2023
Q4 		$473K Buy
4,755
+1,244
+35% +$105K 0.01% 723
2023
Q3 		$363K Sell
3,511
-1,034
-23% -$115K 0.01% 744
2023
Q2 		$552K Sell
4,545
-453
-9% -$60.4K 0.01% 599
2023
Q1 		$768K Sell
4,998
-821
-14% -$135K 0.01% 492
2022
Q4 		$1.05M Buy
5,819
+2,051
+54% +$335K 0.02% 404
2022
Q3 		$446K Sell
3,768
-151
-4% -$22.9K 0.01% 593
2022
Q2 		$560K Buy
3,919
+1,068
+37% +$153K 0.01% 517
2022
Q1 		$491K Buy
2,851
+535
+23% +$90.1K 0.01% 564
2021
Q4 		$588K Sell
2,316
-233
-9% -$68.1K 0.01% 526
2021
Q3 		$981K Buy
2,549
+76
+3% +$28K 0.02% 374
2021
Q2 		$581K Buy
2,473
+351
+17% +$62.7K 0.01% 473
2021
Q1 		$278K Buy
+2,122
New +$307K 0.01% 598
2020
Q4 		– Sell
-17,431
Closed -$1.23M – 692
2020
Q3 		$1.23M Buy
17,431
+3,431
+25% +$239K 0.04% 238
2020
Q2 		$899K Buy
+14,000
New +$767K 0.03% 304

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

MAI Capital Management's MRNA Position: Q2 2026 in Review

MAI Capital Management increased its Moderna (MRNA) stake by 103% in Q2 2026, buying an estimated $114K and bringing the position to 4,345 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #1578.

MAI Capital Management first reported a position in MRNA in Q2 2020 and has held it in 23 quarters since. The position peaked at $1.23M in Q3 2020. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • MAI Capital Management held 4,345 shares of Moderna worth $304K as of Q2 2026.
  • MAI Capital Management bought 2,200 Moderna shares in Q2 2026, an estimated $114K.
  • Moderna made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1578 holding.
  • MAI Capital Management first reported a position in Moderna in Q2 2020 and has held it in 23 quarters since.
  • MAI Capital Management's Moderna position peaked at $1.23M in Q3 2020.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.